Adaptive Biotechnologies Corp (ADPT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 70,495 | 47,920 | 65,064 | 90,030 | 139,065 |
| Marketable Securities | 156,485 | 174,374 | 281,337 | 408,166 | 213,996 |
| Receivables | 50,365 | 41,731 | 37,969 | 40,057 | 17,409 |
| Inventories | 9,820 | 8,440 | 14,448 | 14,453 | 19,263 |
| TOTAL | $300,185 | $283,752 | $410,188 | $562,146 | $402,748 |
| Non-Current Assets | |||||
| PPE Net | 34,107 | 48,616 | 68,227 | 83,447 | 85,262 |
| Investments And Advances | 13,234 | 33,660 | 0 | 0 | 217,145 |
| Intangibles | 120,698 | 122,397 | 124,100 | 125,799 | 127,498 |
| Other Non-Current Assets | 44,512 | 50,951 | 58,619 | 85,225 | 90,691 |
| TOTAL | $212,551 | $255,624 | $250,946 | $294,471 | $520,596 |
| Total Assets | $512,736 | $539,376 | $661,134 | $856,617 | $923,344 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 6,467 | 7,265 | 7,719 | 8,084 | 3,307 |
| Accrued Expenses | 24,692 | 23,995 | 22,282 | 28,359 | 24,985 |
| Other current liabilities | 4,642 | 865 | N/A | N/A | N/A |
| TOTAL | $89,915 | $98,053 | $88,015 | $109,788 | $113,807 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 45,194 | 55,689 | 48,630 | 64,115 | 80,460 |
| Other Non-Current Liabilities | 196,772 | 211,685 | 220,102 | 224,309 | 106,704 |
| TOTAL | $197,820 | $238,838 | $264,841 | $282,731 | $205,435 |
| Total Liabilities | $287,735 | $336,891 | $352,856 | $392,519 | $319,242 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 153,982 | 148,582 | 145,092 | 143,227 | 141,584 |
| Common Shares | 15 | 14 | 14 | 14 | 14 |
| Retained earnings | -1,363,323 | -1,303,824 | -1,144,332 | -919,082 | -718,891 |
| Other shareholders' equity | 6,461 | -58 | 94 | -4,183 | -1,027 |
| TOTAL | $225,001 | $202,485 | $308,278 | $464,098 | $604,102 |
| Total Liabilities And Equity | $512,736 | $539,376 | $661,134 | $856,617 | $923,344 |